357 related articles for article (PubMed ID: 27562100)
1. Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.
Daenzer JM; Jumbo-Lucioni PP; Hopson ML; Garza KR; Ryan EL; Fridovich-Keil JL
Dis Model Mech; 2016 Nov; 9(11):1375-1382. PubMed ID: 27562100
[TBL] [Abstract][Full Text] [Related]
2. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL
J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE).
Mumma JO; Chhay JS; Ross KL; Eaton JS; Newell-Litwa KA; Fridovich-Keil JL
Mol Genet Metab; 2008 Feb; 93(2):160-71. PubMed ID: 17981065
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Hopson ML; Hang D; Liang Y; Jones DP; Fridovich-Keil JL
Dis Model Mech; 2013 Jan; 6(1):84-94. PubMed ID: 22773758
[TBL] [Abstract][Full Text] [Related]
5. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK.
Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T
J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565
[TBL] [Abstract][Full Text] [Related]
6. A Drosophila melanogaster model of classic galactosemia.
Kushner RF; Ryan EL; Sefton JM; Sanders RD; Lucioni PJ; Moberg KH; Fridovich-Keil JL
Dis Model Mech; 2010; 3(9-10):618-27. PubMed ID: 20519569
[TBL] [Abstract][Full Text] [Related]
7. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia.
Ryan EL; DuBoff B; Feany MB; Fridovich-Keil JL
Dis Model Mech; 2012 Nov; 5(6):796-803. PubMed ID: 22736462
[TBL] [Abstract][Full Text] [Related]
8. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Ryan EL; Hopson ML; Bishop HM; Weitner T; Tovmasyan A; Spasojevic I; Batinic-Haberle I; Liang Y; Jones DP; Fridovich-Keil JL
Antioxid Redox Signal; 2014 May; 20(15):2361-71. PubMed ID: 23758052
[TBL] [Abstract][Full Text] [Related]
9. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
[TBL] [Abstract][Full Text] [Related]
10. Drosophila melanogaster Models of Galactosemia.
Daenzer JM; Fridovich-Keil JL
Curr Top Dev Biol; 2017; 121():377-395. PubMed ID: 28057307
[TBL] [Abstract][Full Text] [Related]
11. Hereditary galactosemia.
Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.
Rasmussen SA; Daenzer JMI; Fridovich-Keil JL
J Inherit Metab Dis; 2021 Jan; 44(1):272-281. PubMed ID: 32882063
[TBL] [Abstract][Full Text] [Related]
13. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model.
Slepak T; Tang M; Addo F; Lai K
Mol Genet Metab; 2005 Nov; 86(3):360-71. PubMed ID: 16169270
[TBL] [Abstract][Full Text] [Related]
14. Structure activity relationships of human galactokinase inhibitors.
Liu L; Tang M; Walsh MJ; Brimacombe KR; Pragani R; Tanega C; Rohde JM; Baker HL; Fernandez E; Blackman B; Bougie JM; Leister WH; Auld DS; Shen M; Lai K; Boxer MB
Bioorg Med Chem Lett; 2015 Feb; 25(3):721-7. PubMed ID: 25553891
[TBL] [Abstract][Full Text] [Related]
15. Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models.
Jumbo-Lucioni PP; Parkinson WM; Kopke DL; Broadie K
Hum Mol Genet; 2016 Sep; 25(17):3699-3714. PubMed ID: 27466186
[TBL] [Abstract][Full Text] [Related]
16. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast.
Ross KL; Davis CN; Fridovich-Keil JL
Mol Genet Metab; 2004; 83(1-2):103-16. PubMed ID: 15464425
[TBL] [Abstract][Full Text] [Related]
17. Innovative therapy for Classic Galactosemia - tale of two HTS.
Tang M; Odejinmi SI; Vankayalapati H; Wierenga KJ; Lai K
Mol Genet Metab; 2012 Jan; 105(1):44-55. PubMed ID: 22018723
[TBL] [Abstract][Full Text] [Related]
18. The Galactose Index measured in fibroblasts of GALT deficient patients distinguishes variant patients detected by newborn screening from patients with classical phenotypes.
Welsink-Karssies MM; van Weeghel M; Hollak CEM; Elfrink HL; Janssen MCH; Lai K; Langendonk JG; Oussoren E; Ruiter JPN; Treacy EP; de Vries M; Ferdinandusse S; Bosch AM
Mol Genet Metab; 2020 Mar; 129(3):171-176. PubMed ID: 31954591
[TBL] [Abstract][Full Text] [Related]
19. Genetic and functional studies reveal a novel noncoding variant in GALT associated with a false positive newborn screening result for galactosemia.
Liu Y; Sidhu A; Bean LH; Conway RL; Fridovich-Keil JL
Clin Chim Acta; 2015 Jun; 446():171-4. PubMed ID: 25920691
[TBL] [Abstract][Full Text] [Related]
20. Grip strength in patients with galactosemia and in a galactose-1-phosphate uridylyltransferase (GALT)-null rat model.
Druss JJ; Rudd Zhong Manis J; Potter NL; Fridovich-Keil JL
J Inherit Metab Dis; 2023 Nov; 46(6):1131-1138. PubMed ID: 37776278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
